Supranuclear Palsy, Progressive (diagnosis) < Supranuclear Palsy, Progressive (drug therapy) < Supranuclear Palsy, Progressive (epidemiology)

Facettes :

List of bibliographic references indexed by Supranuclear Palsy, Progressive (drug therapy)

Number of relevant bibliographic references: 16.

Ident.	Authors (with country if any)	Title
000375 (2014)	Günter U. Höglinger [Allemagne] ; Hans-Jürgen Huppertz ; Stefan Wagenpfeil ; María V. Andrés ; Vincente Belloch ; Teresa Le N ; Teodoro Del Ser	Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial.
000683 (2014)	Eduardo Tolosa [Espagne] ; Irene Litvan ; Günter U. Höglinger ; David Burn ; Andrew Lees ; María V. Andrés ; Belén G Mez-Carrillo ; Teresa Le N ; Teodoro Del Ser	A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy.
001C34 (2010)	Sean S. O'Sullivan [Royaume-Uni] ; Atbin Djamshidian [Royaume-Uni, Autriche] ; Zeshan Ahmed [Royaume-Uni] ; Andrew H. Evans [Australie] ; Andrew D. Lawrence [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	Impulsive‐compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy
001D15 (2010)	Tobias Warnecke [Allemagne] ; Stephan Oelenberg [Allemagne] ; Inga Teismann [Allemagne] ; Christina Hamacher [Allemagne] ; Hubertus Lohmann [Allemagne] ; Erich Bernd Ringelstein [Allemagne] ; Rainer Dziewas [Allemagne]	Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy
002224 (2009)	Claudia Schmidt [Allemagne] ; Daniela Berg [Allemagne] ; Herting [Allemagne] ; Silke Prieur [Allemagne] ; Susann Junghanns [Allemagne] ; Katherine Schweitzer [Allemagne] ; Christoph Globas [Allemagne] ; Ludger Schöls [Allemagne] ; Heinz Reichmann [Allemagne] ; Tjalf Ziemssen [Allemagne]	Loss of nocturnal blood pressure fall in various extrapyramidal syndromes
002631 (2008)	Maria Stamelou [Allemagne] ; Alexander Reuss [Allemagne] ; Ulrich Pilatus [Allemagne] ; Jörg Magerkurth [Allemagne] ; Petra Niklowitz [Allemagne] ; Karla M. Eggert [Allemagne] ; Andrea Krisp [Allemagne] ; Thomas Menke [Allemagne] ; Carmen Schade-Brittinger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Günter U. Höglinger [Allemagne]	Short‐term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo‐controlled trial
002853 (2008)	Karen E. Murphy [Australie] ; Tanya Karaconji [Australie] ; Craig D. Hardman [Australie] ; Glenda M. Halliday [Australie]	Excessive dopamine neuron loss in progressive supranuclear palsy
003694 (2005)	Anthony E. Lang [Canada]	Treatment of progressive supranuclear palsy and corticobasal degeneration
003698 (2005)	David J. Burn [Royaume-Uni] ; Naomi M. Warren [Royaume-Uni]	Toward future therapies in progressive supranuclear palsy
003C58 (2004)	Alexander Wolters [Allemagne] ; Joseph Classen [Allemagne] ; Erwin Kunesch [Allemagne] ; Annette Grossmann [Allemagne] ; Reiner Benecke [Allemagne]	Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes
004321 (2002)	Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Mark Fenton [Canada] ; Jeffery R. Donat [Canada] ; Bohdan Rozdilsky [Canada] ; Christopher Robinson [Canada] ; Rob Macaulay [Canada] ; David George [Canada]	Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases
004404 (2002)	Jong-Min Kim [Corée du Sud] ; Ki Hyeong Lee [Corée du Sud] ; Yoon-La Choi [Corée du Sud] ; Gi Yeong Choe [Corée du Sud] ; Beom S. Jeon [Corée du Sud]	Levodopa‐induced dyskinesia in an autopsy‐proven case of progressive supranuclear palsy
005020 (1998)	Rascol [France] ; Kasia Sieradzan [Royaume-Uni] ; Hélène Peyro-Saint-Paul [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Jean Michel Senard [France] ; Philippe Ladure [France] ; Jean Louis Montastruc [France] ; Andrew Lees (neurologue) [Royaume-Uni]	Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy
005375 (1997)	Rajput [Canada] ; M. E. Fenton [Canada] ; D. George [Canada] ; Alex Rajput [États-Unis] ; W. Wilson [Canada] ; L. Mcculloch [Canada]	Concordance of common movement disorders among familial cases
005929 (1995)	V. Lepore [Italie] ; G. Defazio [Italie] ; D. Acquistapace [Italie] ; C. Melpignano [Italie] ; L. Pomes [Italie] ; P. Lamberti [Italie] ; P. Livrea [Italie] ; E. Ferrari [Italie]	Botulinum a toxin for the so‐called apraxia of lid opening
005933 (1995)	Mark [États-Unis] ; J. I. Sage [États-Unis] ; A. S. Walters [États-Unis] ; R. C. Duvoisin [États-Unis] ; D. C. Miller [États-Unis]	Binswanger's disease presenting as levodopa‐responsive parkinsonism: Clinicopathologic study of three cases

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Supranuclear Palsy, Progressive (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Supranuclear Palsy, Progressive (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Supranuclear Palsy, Progressive (drug therapy)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024